Latest News and Press Releases

IRVINE, CA--(Marketwire - Apr 17, 2012) - Biomerica, Inc. (OTCBB: BMRA) today reported net income for the nine months ended February 29, 2012 of $494,329 compared to a net income of $61,354 during...

IRVINE, CA--(Marketwire - Mar 6, 2012) - Biomerica, Inc. (OTCBB: BMRA) announced today that it has introduced two new E. coli tests for detecting verotoxin and E. coli 0157. E. coli is an...

IRVINE, CA--(Marketwire - Jan 31, 2012) - Biomerica, Inc. (OTCBB: BMRA) announced that it has launched a new patented Thiopurine methyltransferase (TPMT) test to detect patients who are at risk of...

IRVINE, CA--(Marketwire - Jan 18, 2012) - Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $1,616,606 for the three months ended November 30, 2011, compared to $1,160,842 for the same...

IRVINE, CA--(Marketwire - Oct 18, 2011) - Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, announced financial results...

IRVINE, CA--(Marketwire - Aug 30, 2011) - Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net income...

IRVINE, CA--(Marketwire - Apr 15, 2011) - Biomerica, Inc. (OTCBB: BMRA) today reported net income for the nine months ended February 28, 2011 of $61,354 compared to a net loss of $164,147 during the...

IRVINE, CA--(Marketwire - January 17, 2011) - Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $1,160,842 for the three months ended November 30, 2010, compared to $1,099,880 for the same...

IRVINE, CA--(Marketwire - November 30, 2010) - Biomerica, Inc. (OTCBB: BMRA) today announced that the company has been awarded over $357,000 in grants under the Qualifying Therapeutic Discovery...

IRVINE, CA--(Marketwire - October 18, 2010) -  Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported...